Audiologists in Myrtle Beach, SC Accepting Medicare
6 Audiologists found. Showing 1 - 6
 Dr. Willa Fry, AU.D. Audiologist Medicare: Not Enrolled in Medicare Practice Location: 1101 Johnson Ave, Suite 204, Myrtle Beach, SC 29577 Phone: 843-477-0177 |
 Beach Audiology Audiologist Medicare: Medicare Enrolled Practice Location: 950 48th Ave N Ste 101, Myrtle Beach, SC 29577 Phone: 843-491-9008 Fax: 843-491-9009 |
Dr. Pamela S. Benbow, AU.D. Audiologist Medicare: Not Enrolled in Medicare Practice Location: 5913 N Kings Hwy, Myrtle Beach, SC 29577 Phone: 843-497-6156 Fax: 843-449-9946 |
Dana M Stephenson, AU.D. Audiologist Medicare: Medicare Enrolled Practice Location: 1101 Johnson Ave, Myrtle Beach, SC 29577 Phone: 843-477-0177 |
Dr. Ashton Moss, AUD Audiologist Medicare: Medicare Enrolled Practice Location: 1021 Cipriana Dr Ste 220, Myrtle Beach, SC 29572 Phone: 843-449-6449 |
Hearing Health Care, P. A. Audiologist Medicare: Not Enrolled in Medicare Practice Location: 5913 N Kings Hwy, Myrtle Beach, SC 29577 Phone: 843-497-6156 Fax: 843-449-9946 |
News Archive
Self-treatment for back pain: Sensory motor learning
Many people with back pain do not know what is causing it and they do not receive effective treatment, but learning to move in a more integrated way makes a big difference, reveals research from the Sahlgrenska Academy at the University of Gothenburg, Sweden.
B-cell substances may play a role in MS progression
Wayne State University School of Medicine researchers, working with colleagues in Canada, have found that one or more substances produced by a type of immune cell in people with multiple sclerosis (MS) may play a role in the disease's progression. The finding could lead to new targeted therapies for MS treatment.
FDA approves FASLODEX 500mg dose for metastatic breast cancer in postmenopausal women
AstraZeneca today announced that the U.S. Food and Drug Administration (FDA) has approved the 500mg dose of FASLODEX® (fulvestrant) Injection, replacing the previously approved monthly dose of 250mg, for the treatment of hormone receptor-positive metastatic breast cancer in postmenopausal women with disease progression following antiestrogen therapy.
Study could lead to new diagnostic blood test for Kawasaki disease
For the first time, researchers at University of California San Diego School of Medicine and Imperial College London, with international collaborators, have determined that Kawasaki Disease (KD) can be accurately diagnosed on the basis of the pattern of host gene expression in whole blood. The finding could lead to a diagnostic blood test to distinguish KD from other infectious and inflammatory conditions.
› Verified 2 days ago
Physical Therapists
Speech-Language Pathologists
Chiropractors
Occupational Therapists
Optometrists
Podiatrists
Audiologists